---
$id: https://graph.org.ai/products/commodity/51321806
$type: Product
source: UNSPSC
code: "51321806"
title: "Clofibride"
class: "51321800"
classTitle: "Antihyperlipidemic and hypocholesterolemic fibric acids"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clofibride

**UNSPSC Code**: 51321806
**Class**: [Antihyperlipidemic and hypocholesterolemic fibric acids](Antihyperlipidemic and hypocholesterolemic fibric acids.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent with the molecular formula C16H22ClNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0S9SLS3L93, chemically known as 4-chlorophenoxy isopropionyl 4-hydroxy-n,n-dimethylbutyramide but generally known as clofibride, which bears US NIH Compound Identifier 160134. European Medicines Agency schedules Clofibride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06708MIG. The term CLOFIBRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules clofibride in its Anatomical Therapeutic Chemical (ATC) Classification. CLOFIBRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clofibride under HS 29242995 and SITC 51479. As of Q4 2014, CLOFIBRIDE remains the US FDA Preferred Term for this commodity. Clofibride bears US NLM identifiers UMLS ID C0055909 and NCI Concept Code C78055. SMILES: Clc1ccc(OC(C(=O)OCCCC(=O)N(C)C)(C)C)cc1.

